Chronic Kidney Disease and Left Ventricular Assist Device Patients: A Retrospective Review

Left ventricular assist device (LVAD) implantation remains a valuable long-term option for patients with end-stage heart failure. Often these patients present with multiple comorbidities, including concomitant renal dysfunction. Patients with renal dysfunction prior to LVAD implantation are considered to be at increased risk for bleeding, right ventricular dysfunction, and mortality. Due to this increased risk, it is suggested that patients with end-stage renal disease (ESRD) should be excluded from LVAD implantation, unless they are being considered for heart and kidney transplantation.

Source: Journal of Cardiac Failure - July 31, 2019 Category: Cardiology Authors: Krystina Chickerillo, Ambar A. Andrade, Lisa Kukla, Muhammad Khan, Sheraz Hussain, Nora Krause, Tracy Aicher, Robin Paliga, Kylie Hughes, Christine Johnson, Nicole Graney, Kara Nitti, Sunil Pauwaa, Gregory Macaluso, Anjali Joshi, Christopher Sciamanna, Mu Tags: 452 Source Type: research